Close

Evogene's (EVGN) Biomica Signs Clinical Trial Agreement with Rambam Health Care Campus for Proof-of-Concept Trial of BMC128

Go back to Evogene's (EVGN) Biomica Signs Clinical Trial Agreement with Rambam Health Care Campus for Proof-of-Concept Trial of BMC128
EVOGENE LTD. (NASDAQ: EVGN) Delayed: 0.66 -0.01 (1.49%)
Previous Close $0.67    52 Week High $9.32 
Open $0.65    52 Week Low $5.79 
Day High $0.68    P/E N/A 
Day Low $0.64    EPS $0.00 
Volume 28,248